Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q1)Aug 31, 2025 | (FY)May 31, 2025 | (Q4)May 31, 2025 | (Q3)Feb 28, 2025 | (Q2)Nov 30, 2024 | (Q1)Aug 31, 2024 | (FY)May 31, 2024 | (Q4)May 31, 2024 | (Q3)Feb 29, 2024 | (Q2)Nov 30, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating revenue | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Cost of revenue | ||||||||||
| Gross profit | ||||||||||
| Operating expense | -79.70%2.1K | -95.38%29.71K | -98.08%11.91K | -75.80%2.12K | -11.49%5.34K | 12.20%10.35K | 2,025.81%643.1K | 6,152.96%619.11K | -2.05%8.74K | -8.76%6.03K |
| Selling and administrative expenses | -42.92%1.56K | -97.25%17.46K | -98.13%11.61K | -8.88%1.56K | -58.57%1.56K | -68.68%2.73K | 3,078.52%633.99K | 8,471.23%619.79K | -22.18%1.71K | -38.37%3.77K |
| -General and administrative expense | -42.92%1.56K | -97.25%17.46K | -98.13%11.61K | -8.88%1.56K | -58.57%1.56K | -68.68%2.73K | 3,078.52%633.99K | 8,471.23%619.79K | -22.18%1.71K | -38.37%3.77K |
| Other operating expenses | -92.90%541 | 34.38%12.25K | 143.53%296 | -92.10%555 | 66.75%3.78K | 1,423.80%7.62K | -11.58%9.11K | -125.47%-680 | 4.54%7.03K | 353.00%2.27K |
| Operating profit | 79.70%-2.1K | 95.38%-29.71K | 98.08%-11.91K | 75.80%-2.12K | 11.49%-5.34K | -12.20%-10.35K | -2,025.81%-643.1K | -6,152.96%-619.11K | 2.05%-8.74K | 8.76%-6.03K |
| Net non-operating interest income (expenses) | -19.99%-162.17K | -10.94%-596.45K | -20.01%-162.19K | -18.69%-158.67K | -5.06%-140.44K | -0.01%-135.15K | -0.27%-537.65K | -0.00%-135.15K | -1.11%-133.68K | -0.00%-133.68K |
| Non-operating interest expense | 20.01%162.17K | 10.94%596.37K | 20.01%162.17K | 18.69%158.65K | 5.06%140.42K | 0.00%135.13K | 0.27%537.58K | 0.00%135.13K | 1.11%133.66K | 0.00%133.66K |
| Total other finance cost | ---- | 9.33%82 | -19.05%17 | 9.52%23 | 0.00%21 | 75.00%21 | 4.17%75 | 16.67%21 | 16.67%21 | 16.67%21 |
| Other net income (expenses) | -2 | |||||||||
| Special income (charges) | ---- | ---2 | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- |
| -Less:Impairment of capital assets | ---- | --2 | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- |
| Income before tax | -12.90%-164.27K | 46.97%-626.16K | 76.92%-174.1K | -12.89%-160.79K | -4.34%-145.78K | -0.79%-145.5K | -108.45%-1.18M | -420.01%-754.26K | -0.91%-142.42K | 0.41%-139.71K |
| Income tax | ||||||||||
| Earnings from equity interest net of tax | ||||||||||
| Net income | -12.90%-164.27K | 46.97%-626.16K | 76.92%-174.1K | -12.89%-160.79K | -4.34%-145.78K | -0.79%-145.5K | -108.45%-1.18M | -420.01%-754.26K | -0.91%-142.42K | 0.41%-139.71K |
| Net income continuous operations | -12.90%-164.27K | 46.97%-626.16K | 76.92%-174.1K | -12.89%-160.79K | -4.34%-145.78K | -0.79%-145.5K | -108.45%-1.18M | -420.01%-754.26K | -0.91%-142.42K | 0.41%-139.71K |
| Noncontrolling interests | ||||||||||
| Net income attributable to the company | -12.90%-164.27K | 46.97%-626.16K | 76.92%-174.1K | -12.89%-160.79K | -4.34%-145.78K | -0.79%-145.5K | -108.45%-1.18M | -420.01%-754.26K | -0.91%-142.42K | 0.41%-139.71K |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | ||||||||||
| Net income attributable to common stockholders | -12.90%-164.27K | 46.97%-626.16K | 76.92%-174.1K | -12.89%-160.79K | -4.34%-145.78K | -0.79%-145.5K | -108.45%-1.18M | -420.01%-754.26K | -0.91%-142.42K | 0.41%-139.71K |
| Diluted earnings per share | 0 | 50.00%-0.01 | 0 | 0 | 0 | 0 | -100.00%-0.02 | -343.26%-0.01 | 0 | 0 |
| Basic earnings per share | 0 | 50.00%-0.01 | 0 | 0 | 0 | 0 | -100.00%-0.02 | -275.23%-0.01 | 0 | 0 |
| Dividend per share | ||||||||||
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.